Alnylam Pharmaceuticals, Inc. financial data

Symbol
ALNY on Nasdaq
Industry
Pharmaceutical Preparations
Location
675 West Kendall Street, Henri A. Termeer Square, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 310 % -10.9%
Quick Ratio 9.27 % -41.6%
Debt-to-equity -2.65K % -60%
Return On Equity 47.9 % -89.9%
Return On Assets -1.88 % +93.9%
Operating Margin -75.7 % +9.84%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 128M shares +2.7%
Common Stock, Shares, Outstanding 128M shares +2.5%
Entity Public Float 23.7B USD +34.4%
Common Stock, Value, Issued 1.28M USD +2.48%
Weighted Average Number of Shares Outstanding, Basic 127M shares +1.66%
Weighted Average Number of Shares Outstanding, Diluted 127M shares +1.66%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.04B USD +22.9%
Revenue from Contract with Customer, Excluding Assessed Tax 2.34B USD +89.5%
Research and Development Expense 1.08B USD +9.52%
Costs and Expenses 2.24B USD +8.63%
Operating Income (Loss) 103M USD
Nonoperating Income (Expense) -164M USD +29.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -61.7M USD +94.2%
Income Tax Expense (Benefit) 11.2M USD +181%
Net Income (Loss) Attributable to Parent -72.9M USD +93.1%
Earnings Per Share, Basic -0.56 USD/shares +93.5%
Earnings Per Share, Diluted -0.56 USD/shares +93.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 968M USD +47.2%
Accounts Receivable, after Allowance for Credit Loss, Current 309M USD +40.3%
Inventory, Net 84M USD -16.4%
Assets, Current 3.17B USD +25.7%
Property, Plant and Equipment, Net 517M USD -1.96%
Operating Lease, Right-of-Use Asset 198M USD -5.03%
Other Assets, Noncurrent 71.9M USD -22.4%
Assets 4.01B USD +17.8%
Accounts Payable, Current 74M USD +23.8%
Employee-related Liabilities, Current 122M USD -6.52%
Accrued Liabilities, Current 809M USD +35.1%
Contract with Customer, Liability, Current 69M USD +26.3%
Liabilities, Current 1.06B USD +33.8%
Contract with Customer, Liability, Noncurrent 2.4M USD -98.8%
Operating Lease, Liability, Noncurrent 239M USD -5.55%
Other Liabilities, Noncurrent 350M USD +36.3%
Liabilities 4.01B USD +5.31%
Accumulated Other Comprehensive Income (Loss), Net of Tax -34.6M USD +6.59%
Retained Earnings (Accumulated Deficit) -7.09B USD -1.04%
Stockholders' Equity Attributable to Parent -3.07M USD +99.2%
Liabilities and Equity 4.01B USD +17.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -81.5M USD +51%
Net Cash Provided by (Used in) Financing Activities 28.9M USD -37.7%
Net Cash Provided by (Used in) Investing Activities -67.6M USD +11.3%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 128M shares +2.5%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -130M USD +33%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 971M USD +47.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 30.9M USD +122%
Deferred Tax Assets, Valuation Allowance 2.82B USD +28.4%
Deferred Tax Assets, Gross 2.9B USD +26.3%
Operating Lease, Liability 285M USD -6.16%
Payments to Acquire Property, Plant, and Equipment 13M USD -6.61%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -70.5M USD +93.3%
Lessee, Operating Lease, Liability, to be Paid 418M USD -9.15%
Property, Plant and Equipment, Gross 749M USD +7.49%
Operating Lease, Liability, Current 41.7M USD -0.99%
Lessee, Operating Lease, Liability, to be Paid, Year Two 46.4M USD -0.25%
Lessee, Operating Lease, Liability, to be Paid, Year One 43.6M USD +1.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 133M USD -14.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 40.6M USD -5.18%
Deferred Tax Assets, Operating Loss Carryforwards 803M USD 0%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 39M USD -3.39%
Operating Lease, Payments 10.7M USD +17.8%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 241M USD -16.1%
Interest Expense 128M USD -10.6%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%